Maury Raycroft
Stock Analyst at Jefferies
(4.47)
# 1,131
Out of 5,076 analysts
243
Total ratings
42%
Success rate
11.5%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics | Initiated Coverage: Buy | $25 | $8.03 | +211.33% | 1 | Oct 22, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | $112 | $87.63 | +27.81% | 6 | Oct 5, 2026 | |
| QTTB Q32 Bio | Reiterated: Buy | $29 | $8.65 | +235.26% | 2 | Oct 1, 2026 | |
| ANL Adlai Nortye Group | Initiated Coverage: Buy | $31 | $10.58 | +193.01% | 1 | Sep 10, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $77 → $28 | $15.65 | +78.91% | 16 | Sep 3, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $47 → $10 | $1.88 | +431.91% | 2 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $44 → $42 | $20.45 | +105.38% | 7 | Aug 5, 2026 | |
| KPTI Karyopharm Therapeutics | Reiterated: Buy | $35 → $11 | $0.5175 | +2,025.60% | 7 | Jul 31, 2026 | |
| ERAS Erasca | Rated: Buy | $21 → $24 | $14.39 | +66.78% | 3 | Jul 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Reiterated: Buy | $39 → $47 | $34.40 | +36.63% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $27 → $60 | $23.34 | +157.07% | 3 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $76.78 | +71.92% | 6 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $33 | $4.05 | +714.81% | 7 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.55 | +238.03% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $0.761 | +1,082.65% | 4 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $52 | $34.71 | +49.81% | 2 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $5.26 | +185.17% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $1.56 | +1,694.87% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $3.86 | +418.81% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $16.86 | +24.56% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.63 | -1.84% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $549 | $224.03 | +145.06% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $15 | $7.65 | n/a | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $24.05 | n/a | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $50.08 | n/a | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $79 | $65.25 | n/a | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $23 | $13.17 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $0.9073 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.96 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $9 | $3.67 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $15 | $5.92 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $1.5 | $0.115 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.2817 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $0.8056 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $0.0001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $18.66 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.511 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $27.99 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $58.02 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $49.39 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $0.4311 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $109 | $11.21 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $25 | $8.59 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $86 | $24.03 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $6.64 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $35.34 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $4.40 | n/a | 2 | May 22, 2018 |
Candel Therapeutics
Oct 22, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $8.03
Upside: +211.33%
Kodiak Sciences
Oct 5, 2026
Reiterated: Buy
Price Target: $112
Current: $87.63
Upside: +27.81%
Q32 Bio
Oct 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.65
Upside: +235.26%
Adlai Nortye Group
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $10.58
Upside: +193.01%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $77 → $28
Current: $15.65
Upside: +78.91%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $47 → $10
Current: $1.88
Upside: +431.91%
Tyra Biosciences
Aug 5, 2026
Reiterated: Buy
Price Target: $44 → $42
Current: $20.45
Upside: +105.38%
Karyopharm Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $35 → $11
Current: $0.5175
Upside: +2,025.60%
Erasca
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $14.39
Upside: +66.78%
Hemab Therapeutics Holdings
Jul 13, 2026
Reiterated: Buy
Price Target: $39 → $47
Current: $34.40
Upside: +36.63%
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $23.34
Upside: +157.07%
Jun 15, 2026
Reiterated: Buy
Price Target: $132
Current: $76.78
Upside: +71.92%
May 12, 2026
Reiterated: Buy
Price Target: $53 → $33
Current: $4.05
Upside: +714.81%
Apr 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.55
Upside: +238.03%
Apr 27, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $0.761
Upside: +1,082.65%
Apr 5, 2026
Reiterated: Buy
Price Target: $14 → $52
Current: $34.71
Upside: +49.81%
Mar 23, 2026
Reiterated: Buy
Price Target: $14 → $15
Current: $5.26
Upside: +185.17%
Feb 25, 2026
Reiterated: Buy
Price Target: $28
Current: $1.56
Upside: +1,694.87%
Dec 8, 2025
Reiterated: Buy
Price Target: $15 → $20
Current: $3.86
Upside: +418.81%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $16.86
Upside: +24.56%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.63
Upside: -1.84%
Oct 30, 2025
Reiterated: Buy
Price Target: $384 → $549
Current: $224.03
Upside: +145.06%
Oct 14, 2025
Reiterated: Buy
Price Target: $14 → $15
Current: $7.65
Upside: n/a
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $24.05
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $50.08
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $33 → $79
Current: $65.25
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40 → $23
Current: $13.17
Upside: n/a
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $0.9073
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $8
Current: $3.96
Upside: n/a
May 19, 2025
Reiterated: Buy
Price Target: $15 → $9
Current: $3.67
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $7 → $15
Current: $5.92
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $2 → $1.5
Current: $0.115
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.2817
Upside: n/a
Nov 13, 2024
Rated: Buy
Price Target: $21
Current: $0.8056
Upside: n/a
Apr 4, 2024
Reiterated: Buy
Price Target: $10 → $20
Current: $0.0001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $18.66
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $0.511
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $27.99
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $75
Current: $58.02
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $49.39
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $0.4311
Upside: n/a
Jun 22, 2021
Reiterated: Buy
Price Target: $37 → $109
Current: $11.21
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $14 → $25
Current: $8.59
Upside: n/a
Jul 29, 2020
Reiterated: Buy
Price Target: $34 → $86
Current: $24.03
Upside: n/a
May 18, 2020
Reiterated: Buy
Price Target: $25
Current: $6.64
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $35.34
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $4.40
Upside: n/a